Incidence of adverse events during the 28 days following CHMI.

1A single subject accounted for all severe AEs which appeared on the day of positive blood smear, and all of which decreased in severity within 24 hours of treatment.2Per episode (number of episodes/subjects reporting episodes).3Only symptoms reported from day 0 through day 5 are included.4Only symptoms reported from day 6 through day 28 and determined by the Investigator to be malaria-related are included.5Collected throughout the 56 day study.Incidence of adverse events during the 28 days following CHMI.